Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2007 1
2008 1
2009 2
2010 1
2011 3
2013 3
2014 2
2015 5
2016 6
2017 4
2018 8
2019 2
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint therapy in liver cancer.
Xu F, Jin T, Zhu Y, Dai C. Xu F, et al. Among authors: zhu y. J Exp Clin Cancer Res. 2018 May 29;37(1):110. doi: 10.1186/s13046-018-0777-4. J Exp Clin Cancer Res. 2018. PMID: 29843754 Free PMC article. Review.
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.
Kolb R, Kluz P, Tan ZW, Borcherding N, Bormann N, Vishwakarma A, Balcziak L, Zhu P, Davies BS, Gourronc F, Liu LZ, Ge X, Jiang BH, Gibson-Corley K, Klingelhutz A, Tan NS, Zhu Y, Sutterwala FS, Shen X, Zhang W. Kolb R, et al. Among authors: zhu y. Oncogene. 2019 Mar;38(13):2351-2363. doi: 10.1038/s41388-018-0592-6. Epub 2018 Dec 5. Oncogene. 2019. PMID: 30518876 Free PMC article.
Identification of CD112R as a novel checkpoint for human T cells.
Zhu Y, Paniccia A, Schulick AC, Chen W, Koenig MR, Byers JT, Yao S, Bevers S, Edil BH. Zhu Y, et al. J Exp Med. 2016 Feb 8;213(2):167-76. doi: 10.1084/jem.20150785. Epub 2016 Jan 11. J Exp Med. 2016. PMID: 26755705 Free PMC article.
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y. Xu F, et al. Among authors: zhu y. Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16. Cancer Immunol Immunother. 2017. PMID: 28623459 Free PMC article.
Mitochondrial metabolic reprogramming: An important player in liver cancer progression.
Jin T, Wang C, Tian Y, Dai C, Zhu Y, Xu F. Jin T, et al. Among authors: zhu y. Cancer Lett. 2020 Feb 1;470:197-203. doi: 10.1016/j.canlet.2019.11.029. Epub 2019 Nov 26. Cancer Lett. 2020. PMID: 31783085 Review.
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.
Fujiwara Y, Sun Y, Torphy RJ, He J, Yanaga K, Edil BH, Schulick RD, Zhu Y. Fujiwara Y, et al. Among authors: zhu y. Cancer Res. 2018 Dec 1;78(23):6655-6665. doi: 10.1158/0008-5472.CAN-18-1781. Epub 2018 Oct 12. Cancer Res. 2018. PMID: 30315115 Free article.
B7-h2 is a costimulatory ligand for CD28 in human.
Yao S, Zhu Y, Zhu G, Augustine M, Zheng L, Goode DJ, Broadwater M, Ruff W, Flies S, Xu H, Flies D, Luo L, Wang S, Chen L. Yao S, et al. Among authors: zhu y. Immunity. 2011 May 27;34(5):729-40. doi: 10.1016/j.immuni.2011.03.014. Epub 2011 Apr 28. Immunity. 2011. PMID: 21530327 Free PMC article.
B7-H5 costimulates human T cells via CD28H.
Zhu Y, Yao S, Iliopoulou BP, Han X, Augustine MM, Xu H, Phennicie RT, Flies SJ, Broadwater M, Ruff W, Taube JM, Zheng L, Luo L, Zhu G, Chen J, Chen L. Zhu Y, et al. Nat Commun. 2013;4:2043. doi: 10.1038/ncomms3043. Nat Commun. 2013. PMID: 23784006 Free PMC article.
CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers.
Tian Y, Sun Y, Gao F, Koenig MR, Sunderland A, Fujiwara Y, Torphy RJ, Chen L, Edil BH, Schulick RD, Zhu Y. Tian Y, et al. Among authors: zhu y. Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019. Oncoimmunology. 2018. PMID: 30713797 Free PMC article.
Immunotherapy for pancreatic cancer: Barriers and breakthroughs.
Torphy RJ, Zhu Y, Schulick RD. Torphy RJ, et al. Among authors: zhu y. Ann Gastroenterol Surg. 2018 Jun 22;2(4):274-281. doi: 10.1002/ags3.12176. eCollection 2018 Jul. Ann Gastroenterol Surg. 2018. PMID: 30003190 Free PMC article. Review.
40 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback